846 A new case series of olmsted syndrome subjects confirms EGFR activation and long term efficacity of oral erlotinib with acceptable tolerance.
J. Basset, Y. Diab, F. Santiago, L. Azulay, K. Cordoro, A. Zhang, F. Watanabe, A. Kirkorian, F. Frascari, D. Siegel, E. Bourrat, R. Howard, A. Hovnanian
PMID: